Global strategy for asthma management and prevention: GINA executive summary - PubMed (original) (raw)
doi: 10.1183/09031936.00138707.
S S Hurd, P J Barnes, J Bousquet, J M Drazen, J M FitzGerald, P Gibson, K Ohta, P O'Byrne, S E Pedersen, E Pizzichini, S D Sullivan, S E Wenzel, H J Zar
Affiliations
- PMID: 18166595
- DOI: 10.1183/09031936.00138707
Free article
Global strategy for asthma management and prevention: GINA executive summary
E D Bateman et al. Eur Respir J. 2008 Jan.
Free article
Erratum in
- "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143-178.
[No authors listed] [No authors listed] Eur Respir J. 2018 Jan 31;51(2):0751387. doi: 10.1183/13993003.51387-2007. Print 2018 Feb. Eur Respir J. 2018. PMID: 29386342 No abstract available.
Abstract
Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effectively. However, recommendations for asthma care need to be adapted to local conditions, resources and services. Since it was formed in 1993, the Global Initiative for Asthma, a network of individuals, organisations and public health officials, has played a leading role in disseminating information about the care of patients with asthma based on a process of continuous review of published scientific investigations. A comprehensive workshop report entitled "A Global Strategy for Asthma Management and Prevention", first published in 1995, has been widely adopted, translated and reproduced, and forms the basis for many national guidelines. The 2006 report contains important new themes. First, it asserts that "it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained," and recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. The importance of the patient-care giver partnership and guided self-management, along with setting goals for treatment, are also emphasised.
Similar articles
- The revised 2014 GINA strategy report: opportunities for change.
Boulet LP, FitzGerald JM, Reddel HK. Boulet LP, et al. Curr Opin Pulm Med. 2015 Jan;21(1):1-7. doi: 10.1097/MCP.0000000000000125. Curr Opin Pulm Med. 2015. PMID: 25405667 Review. - Global strategy for the diagnosis and management of asthma in children 5 years and younger.
Pedersen SE, Hurd SS, Lemanske RF Jr, Becker A, Zar HJ, Sly PD, Soto-Quiroz M, Wong G, Bateman ED; Global Initiative for Asthma. Pedersen SE, et al. Pediatr Pulmonol. 2011 Jan;46(1):1-17. doi: 10.1002/ppul.21321. Epub 2010 Oct 20. Pediatr Pulmonol. 2011. PMID: 20963782 - A summary of the new GINA strategy: a roadmap to asthma control.
Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, Haahtela T, Hurd SS, Inoue H, de Jongste JC, Lemanske RF Jr, Levy ML, O'Byrne PM, Paggiaro P, Pedersen SE, Pizzichini E, Soto-Quiroz M, Szefler SJ, Wong GW, FitzGerald JM. Reddel HK, et al. Eur Respir J. 2015 Sep;46(3):622-39. doi: 10.1183/13993003.00853-2015. Epub 2015 Jul 23. Eur Respir J. 2015. PMID: 26206872 Free PMC article. Review. - Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
National Asthma Education and Prevention Program. National Asthma Education and Prevention Program. J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. doi: 10.1016/j.jaci.2007.09.043. J Allergy Clin Immunol. 2007. PMID: 17983880 - Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?
Reddel HK. Reddel HK. J Allergy Clin Immunol. 2015 Sep;136(3):546-52. doi: 10.1016/j.jaci.2015.06.043. J Allergy Clin Immunol. 2015. PMID: 26343938
Cited by
- The Relationship between Depression and Asthma: A Meta-Analysis of Prospective Studies.
Gao YH, Zhao HS, Zhang FR, Gao Y, Shen P, Chen RC, Zhang GJ. Gao YH, et al. PLoS One. 2015 Jul 21;10(7):e0132424. doi: 10.1371/journal.pone.0132424. eCollection 2015. PLoS One. 2015. PMID: 26197472 Free PMC article. - Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
Xie M, Wang W, Dou S, Cui L, Xiao W. Xie M, et al. Int J Chron Obstruct Pulmon Dis. 2016 May 6;11:953-61. doi: 10.2147/COPD.S104484. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27226711 Free PMC article. - 17q21 Variants Disturb Mucosal Host Defense in Childhood Asthma.
Jakwerth CA, Weckmann M, Illi S, Charles H, Zissler UM, Oelsner M, Guerth F, Omony J, Nemani SSP, Grychtol R, Dittrich AM, Skevaki C, Foth S, Weber S, Alejandre Alcazar MA, van Koningsbruggen-Rietschel S, Brock R, Blau S, Hansen G, Bahmer T, Rabe KF, Brinkmann F, Kopp MV, Chaker AM, Schaub B, von Mutius E, Schmidt-Weber CB; ALLIANCE Study Group as part of the German Center for Lung Research. Jakwerth CA, et al. Am J Respir Crit Care Med. 2024 Apr 15;209(8):947-959. doi: 10.1164/rccm.202305-0934OC. Am J Respir Crit Care Med. 2024. PMID: 38064241 Free PMC article. - Allergic fungal airways disease (AFAD): an under-recognised asthma endotype.
Pashley CH, Wardlaw AJ. Pashley CH, et al. Mycopathologia. 2021 Oct;186(5):609-622. doi: 10.1007/s11046-021-00562-0. Epub 2021 May 27. Mycopathologia. 2021. PMID: 34043134 Free PMC article. Review. - In Vitro Effects of 5-Lipoxygenase Pathway Inhibition on Rhinovirus-Associated Bronchial Epithelial Inflammation.
Spyridaki I, Taka S, Skevaki C, Trochoutsou A, Papadopoulos NG. Spyridaki I, et al. Pulm Ther. 2021 Jun;7(1):237-249. doi: 10.1007/s41030-021-00152-x. Epub 2021 Apr 13. Pulm Ther. 2021. PMID: 33847974 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous